Is Amplify Seymour Cannabis ETF (CNBS) a Buy, Sell, or Hold?
AMEX : CNBS
Amplify Seymour Cannabis ETF — News
$26.09 USD
$0.19 (0.72%)
- Volume
- 1.08K
- Average Volume
- 12.78K
- Market Capitalization
- $83.17M
- P/E Ratio
- Dividend Yield
- %
- Price Target
- Year High
- $43.94
- Year Low
- $17.40
- Day High
- —
- Day Low
- —
- Payout Ratio
- Current Ratio
| Source | Headline |
|---|---|
|
Dividend Safety Check: CNBS and Income in the Cannabis Sector
The Amplify Seymour Cannabis ETF (NYSEARCA:CNBS) sits at the awkward intersection of a thematic sector bet and an income wrapper. 247wallst.com - 2026-06-13 10:00:17 |
|
CNBS Rallied Triple Digits On One Regulatory Bet, Not Dividends
The Amplify Seymour Cannabis ETF (NYSEARCA:CNBS) has rallied sharply in 2026, with shares up 105% over the past year and 9% in just the last week. 247wallst.com - 2026-06-09 13:10:50 |
|
US Reclassifies Weed: Can Cannabis ETFs Give Your Portfolio a New High?
Medical marijuana's US reclassification revives cannabis ETFs like WEED, with tax relief and reform hopes fueling sharp gains across the sector. zacks.com - 2026-05-14 14:10:39 |
|
Cannabis Rescheduling Could Unlock the Biggest MSO Rally Since 2021
Federal cannabis policy moved from theory to action this spring, and three ETFs sit closest to the trade. 247wallst.com - 2026-05-06 09:24:22 |
|
Cannabis ETFs: Regulatory Momentum Returns Focus
Cannabis stocks have seen renewed investor interest as federal policy momentum improves. The most important recent development was the placement of FDA-approved marijuana products and state-regulated medical marijuana products from Schedule I to Schedule III under the Controlled Substances Act. etftrends.com - 2026-04-30 07:56:06 |
|
The Last Cannabis ETFs Worth Your Money: Why Most Failed and 3 Are Still Trading
Cannabis ETFs entered 2026 after multiple fund closures, stalled federal reform, and a prolonged multi‑year drawdown in underlying equities. 247wallst.com - 2026-04-23 12:21:51 |
